Home Page
Companies in Latin America's Pharmaceutical & Biotech Industry have delayed the authorizations for expenditure on 93 capital-spending projects, with a total investment value of more than $245 million, during the second quarter of 2020. This period has seen a tightening of lockdowns and restrictions related to the COVID-19 pandemic.
(All Fields Required)
Site-wide Scheduled Maintenance for September 27, 2025 from 12 P.M. to 6 P.M. CDT. Expect intermittent web site availability during this time period.
×Contact Us
For More Info!
